Sign in
4

Changes in Ownership

Sarepta Therapeutics, Inc. Filed Acc 0001209191-19-021876

EVP, General Counsel gave up 2,362 shares (to pay taxes)

  • EVP, General Counsel acquired 5,319 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Howton David T · EVP, General Counsel

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2019-03-28 Grant or award : show line 1 in the form +5,319 21,065 D
2019-03-28 Shares withheld for taxes : show line 2 in the form −2,362 $118.68 $280,322 18,703 D
Loading xslF345X03/doc4.xml…